At a glance
ClinicalIndex Comparison RecordN/ACompleted· 230 enrolled
Drug / intervention
Coronary angioplastyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Defining a Gold Standard for Ischaemia: Effects of Interventional Revascularisation Versus Optimum Medical Therapy on Exercise Capacity in Patients With Stable Coronary Artery Disease
In Brief
A clinical study evaluating Coronary angioplasty for Stable Angina. Completed, enrolled 230 participants across 5 sites.
Detailed Summary
In this study the investigators will use careful scientific blinding of patient and their subsequent healthcare staff so that the investigators can determine exactly how much difference coronary angioplasty makes to symptoms and blood supply to the heart. After the 6 weeks blinded phase, all patients will be unblinded and the patients who had undergone sham procedure will be offered the active therapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStable Angina
CountriesUnited Kingdom
CollaboratorsVolcano Corporation
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartDec 2013
First PostedFeb 2014
Primary CompletionAug 2017
Study CompletionSep 2017
TodayJul 2026
First PostedFeb 13, 2014
Enrollment StartDec 1, 2013
Primary CompletionAug 1, 2017
Study CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 12.4 years ago
Interventions
Coronary angioplastyprocedure
Percutaneous coronary intervention with drug-eluting stents and modern techniques